ATE209659T1 - Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren - Google Patents

Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren

Info

Publication number
ATE209659T1
ATE209659T1 AT95933880T AT95933880T ATE209659T1 AT E209659 T1 ATE209659 T1 AT E209659T1 AT 95933880 T AT95933880 T AT 95933880T AT 95933880 T AT95933880 T AT 95933880T AT E209659 T1 ATE209659 T1 AT E209659T1
Authority
AT
Austria
Prior art keywords
react
broadly reactive
opsonic antibodies
common staphylococcus
staphylococcus antigens
Prior art date
Application number
AT95933880T
Other languages
English (en)
Inventor
Gerald W Fisher
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23194201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE209659(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of ATE209659T1 publication Critical patent/ATE209659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT95933880T 1994-09-21 1995-09-21 Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren ATE209659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30849594A 1994-09-21 1994-09-21
PCT/US1995/011992 WO1996009321A1 (en) 1994-09-21 1995-09-21 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens

Publications (1)

Publication Number Publication Date
ATE209659T1 true ATE209659T1 (de) 2001-12-15

Family

ID=23194201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933880T ATE209659T1 (de) 1994-09-21 1995-09-21 Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren

Country Status (10)

Country Link
EP (1) EP0783520B1 (de)
JP (1) JP4160633B2 (de)
AT (1) ATE209659T1 (de)
AU (1) AU707298B2 (de)
CA (1) CA2200691C (de)
DE (1) DE69524242T2 (de)
DK (1) DK0783520T3 (de)
ES (1) ES2169153T3 (de)
PT (1) PT783520E (de)
WO (1) WO1996009321A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
IT1298539B1 (it) 1998-02-03 2000-01-12 Bracco Spa Metodo per la determinazione di infezioni da protesi
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US8445000B2 (en) * 2004-10-21 2013-05-21 Wyeth Llc Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens
JP5395264B2 (ja) 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
ATE197506T1 (de) * 1992-03-19 2000-11-11 Jackson H M Found Military Med Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren

Also Published As

Publication number Publication date
JP4160633B2 (ja) 2008-10-01
JP2000509961A (ja) 2000-08-08
CA2200691C (en) 2011-02-15
PT783520E (pt) 2002-05-31
ES2169153T3 (es) 2002-07-01
DK0783520T3 (da) 2002-03-25
CA2200691A1 (en) 1996-03-28
EP0783520A1 (de) 1997-07-16
DE69524242T2 (de) 2002-05-23
EP0783520B1 (de) 2001-11-28
WO1996009321A1 (en) 1996-03-28
DE69524242D1 (de) 2002-01-10
AU707298B2 (en) 1999-07-08
AU3637195A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
ATE197506T1 (de) Breitreaktive opsonische antikörper die mit gemeinsamen antigenen von staphylococcus reagieren
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
DE60112744D1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
EP0077734A3 (de) Herstellung von monoklonalen Antikörpern gegen bakterielle Adhesine
TR200200633T2 (tr) Yeni streptococcus antijenleri
MX9603773A (es) Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
HK1048831A1 (en) Human ctla-4 antibodies and their uses
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
EP0350690A3 (de) Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente
GB0008305D0 (en) Treatment of fungal infections
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
ATE209659T1 (de) Breit-reaktive opsonische antikörper, die mit gemeinsamen staphylococcus-antigenen reagieren
NO973875D0 (no) Fremgangsmåte for simulering av en immunrespons
CA2297694A1 (en) Antibodies and diagnostic methods for the diagnosis of pestviruses
DE68924963D1 (de) Zusammensetzungen und Methoden zur Behandlung und Vorbeugung von Gram-Negativen-Infektionen.
EP0450573A3 (de) Antikörper für die Behandlung und die Diagnose von Pseudomonas aeruginosa Infektionen
ITTO911003A0 (it) Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.
EP1219635A3 (de) Chlamydia pneumoniae Antigene

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification